CUE
Cue Biopharma
25.50$
-7.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -2,311.5% | -890.6% | -1,030.1% | -259.9% | -3,357.9% | -727.9% | -391.2% | -79.0% | |
| – | – | – | 66.5% | 149.4% | -99.7% | -11.9% | 145.1% | 62.6% | 25.3% | 3.5% | |
| – | – | – | 627.8% | 188.6% | 332.3% | 77.1% | 762.7% | 149.0% | 73.7% | 17.3% | |
| – | – | – | 658.3% | 190.1% | 314.4% | 76.9% | 763.0% | – | – | – | |
| – | – | – | 368.5% | -43.1% | 172.3% | -29.4% | 28.6% | -17.0% | -53.0% | -12.0% | |
| – | – | – | 162.3% | 1.3% | 18.9% | 6.1% | 13.7% | 0.0% | 0.7% | 0.6% | |
| – | – | – | -1,781.4% | 99.7% | 141.3% | 61.0% | -1,976.7% | 455.4% | 0.3% | 0.3% | |
| – | – | – | – | – | – | – | 16.1% | – | – | – | |
| – | – | – | 366.0% | -2.6% | -8.6% | -5.0% | -16.1% | – | – | – | |
| – | – | – | – | 289.2% | 317.0% | 66.9% | 1,169.3% | -36.4% | -43.1% | -16.4% | |
| – | – | – | 366.0% | 1,468.8% | 1,858.2% | 128.7% | 4,310.0% | 216.0% | 110.3% | 95.7% | |
| – | – | – | -3,726.9% | 677.8% | 969.3% | -70.2% | -1,024.7% | -56.4% | -280.5% | 17.0% | |
| – | – | – | -2,473.8% | -891.9% | -1,049.0% | -266.0% | -3,371.6% | -727.9% | -391.9% | -79.6% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.